The government has unveiled high plans to make the UK a world leader in innovation, but the pharmaceutical industry remains …
The impact of practice-based commissioning (PBC) on how NICE guidance is implemented will be explored in a series of regional …
Specialist biopharma company Celgene has bought Pharmion for $2.9 billion in a bid to become a global leader in haematology …
Primary care leaders have called for some of the predicted billions in the NHS budget surplus to be spent on …
The pharma industry and interested NHS researchers will come together in a new initiative aimed at increasing and accelerating clinical …
Last month, Pharmafocus showed how market access can be a platform to build a cohesive strategy that brings together sales, …
Type 2 diabetes driving epidemic Type 2 diabetes poses one of the greatest public health threats of the 21st century. …
Abbott is to develop a diagnostic test for Tarceva to identify patients who could most benefit from the lung cancer …
Regulatory problems and doubts about commercial potential have led Lilly to abandon its late-stage inhaled insulin product. The AIR insulin …
The UK government has pledged to introduce new legislation that will require pharmaceutical companies to disclose all data from clinical …
General practitioners across the UK have voted to accept new working hours that will see surgeries open on Saturday mornings …
Wyeth's Pristiq, a refined version of its top-selling depression treatment Efexor, has been approved in the US. Pristiq (desvenlafaxine) delivers …
UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …
Dr Rowan Hillson has been appointed the new national clinical director for diabetes. Dr Hillson is a consultant physician and …
The pharmaceutical industry has welcomed plans to review how NICE assesses the benefits and costs of drugs, with the hope …
Specialist nurses could help to cut the number of diabetes patients being admitted to hospital as emergency cases, a new …
APP Pharma granted approval for generic anticancer drug APP Pharmaceuticals has received final approval from the FDA of its abbreviated …
The Department of Health has refused to comment on renewed speculation on the future of the UK's medicines pricing system …